Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Plos One
|
August 5, 2011
Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo
Denise da Gama Jaén Batista, Marcos Meuser Batista, Gabriel Melo de Oliveira, et al.
Journal of Molecular Biology
|
August 18, 2010
DNA minor groove induced dimerization of heterocyclic cations: compound structure, binding affinity, and specificity for a TTAA site
Manoj Munde, Arvind Kumar, Raja Nhili, et al.
Journal of Pharmaceutical Sciences
|
November 5, 2013
CYP1A1 and CYP1B1-mediated biotransformation of the antitrypanosomal methamidoxime prodrug DB844 forms novel metabolites through intramolecular rearrangement
Wujian Ju, Sihyung Yang, John H Ansede, et al.
Experimental Parasitology
|
June 13, 2009
Trypanosoma cruzi: activity of heterocyclic cationic molecules in vitro
Michele Gabriele de Oliveira Pacheco, Cristiane França da Silva, Elen Mello de Souza, et al.
Nucleic Acids Research
|
October 25, 2012
Targeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines
Raja Nhili, Paul Peixoto, Sabine Depauw, et al.
Parasitology
|
September 10, 2011
The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro
Cristiane França DA Silva, Anissa Daliry, Patrícia Bernardino DA Silva, et al.
Drug Design, Development and Therapy
|
April 25, 2017
Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of <i>Trypanosoma cruzi</i> infection
Cristiane França da Silva, Denise da Gama Jaén Batista, Julianna Siciliano de Araújo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 26, 2006
CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]
Michael Zhuo Wang, Janelle Y Saulter, Etsuko Usuki, et al.
Antimicrobial Agents and Chemotherapy
|
May 12, 2010
Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment
Denise da Gama Jaén Batista, Marcos Meuser Batista, Gabriel Melo de Oliveira, et al.
Antimicrobial Agents and Chemotherapy
|
April 7, 2010
Novel arylimidamides for treatment of visceral leishmaniasis
Michael Zhuo Wang, Xiaohua Zhu, Anuradha Srivastava, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Plos One
|
August 5, 2011
Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo
Denise da Gama Jaén Batista, Marcos Meuser Batista, Gabriel Melo de Oliveira, et al.
Journal of Molecular Biology
|
August 18, 2010
DNA minor groove induced dimerization of heterocyclic cations: compound structure, binding affinity, and specificity for a TTAA site
Manoj Munde, Arvind Kumar, Raja Nhili, et al.
Journal of Pharmaceutical Sciences
|
November 5, 2013
CYP1A1 and CYP1B1-mediated biotransformation of the antitrypanosomal methamidoxime prodrug DB844 forms novel metabolites through intramolecular rearrangement
Wujian Ju, Sihyung Yang, John H Ansede, et al.
Experimental Parasitology
|
June 13, 2009
Trypanosoma cruzi: activity of heterocyclic cationic molecules in vitro
Michele Gabriele de Oliveira Pacheco, Cristiane França da Silva, Elen Mello de Souza, et al.
Nucleic Acids Research
|
October 25, 2012
Targeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines
Raja Nhili, Paul Peixoto, Sabine Depauw, et al.
Parasitology
|
September 10, 2011
The efficacy of novel arylimidamides against Trypanosoma cruzi in vitro
Cristiane França DA Silva, Anissa Daliry, Patrícia Bernardino DA Silva, et al.
Drug Design, Development and Therapy
|
April 25, 2017
Phenotypic evaluation and in silico ADMET properties of novel arylimidamides in acute mouse models of <i>Trypanosoma cruzi</i> infection
Cristiane França da Silva, Denise da Gama Jaén Batista, Julianna Siciliano de Araújo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 26, 2006
CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]
Michael Zhuo Wang, Janelle Y Saulter, Etsuko Usuki, et al.
Antimicrobial Agents and Chemotherapy
|
May 12, 2010
Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment
Denise da Gama Jaén Batista, Marcos Meuser Batista, Gabriel Melo de Oliveira, et al.
Antimicrobial Agents and Chemotherapy
|
April 7, 2010
Novel arylimidamides for treatment of visceral leishmaniasis
Michael Zhuo Wang, Xiaohua Zhu, Anuradha Srivastava, et al.
Page
of 5